MRK vs. ABBV
Compare and contrast key facts about Merck & Co., Inc. (MRK) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MRK or ABBV.
Correlation
The correlation between MRK and ABBV is 0.43, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
MRK vs. ABBV - Performance Comparison
Key characteristics
MRK:
-1.34
ABBV:
0.62
MRK:
-1.78
ABBV:
0.94
MRK:
0.76
ABBV:
1.14
MRK:
-0.87
ABBV:
0.82
MRK:
-1.65
ABBV:
2.05
MRK:
19.22%
ABBV:
7.66%
MRK:
23.69%
ABBV:
25.28%
MRK:
-68.62%
ABBV:
-45.09%
MRK:
-33.50%
ABBV:
-6.93%
Fundamentals
MRK:
$218.22B
ABBV:
$356.70B
MRK:
$6.74
ABBV:
$2.38
MRK:
12.82
ABBV:
84.72
MRK:
0.79
ABBV:
0.43
MRK:
$48.39B
ABBV:
$44.02B
MRK:
$39.64B
ABBV:
$33.24B
MRK:
$19.98B
ABBV:
$12.60B
Returns By Period
In the year-to-date period, MRK achieves a -12.41% return, which is significantly lower than ABBV's 14.54% return. Over the past 10 years, MRK has underperformed ABBV with an annualized return of 7.97%, while ABBV has yielded a comparatively higher 18.20% annualized return.
MRK
-12.41%
-5.86%
-20.28%
-31.52%
6.74%
7.97%
ABBV
14.54%
-2.95%
4.98%
17.86%
27.77%
18.20%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MRK vs. ABBV — Risk-Adjusted Performance Rank
MRK
ABBV
MRK vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MRK vs. ABBV - Dividend Comparison
MRK's dividend yield for the trailing twelve months is around 3.66%, more than ABBV's 3.12% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRK Merck & Co., Inc. | 3.66% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% |
ABBV AbbVie Inc. | 3.12% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
MRK vs. ABBV - Drawdown Comparison
The maximum MRK drawdown since its inception was -68.62%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for MRK and ABBV. For additional features, visit the drawdowns tool.
Volatility
MRK vs. ABBV - Volatility Comparison
Merck & Co., Inc. (MRK) has a higher volatility of 7.09% compared to AbbVie Inc. (ABBV) at 6.11%. This indicates that MRK's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MRK vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Merck & Co., Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities